27 nov.: Euler Hermes : Projet d'offre publique d'achat simplifiée visant ..
27 nov.: GENFIT : Contribution significative à l'initiative européenne LIT..
27/11/2017 08:00:08


Related content


Brussels, Monday November 27, 2017, 8h00 ---  According to the Belgian transparency legislation in force (Law of May 2, 2007), SOLVAC SA, located at Rue des Champs Elysées 43 - 1050 Brussels - Belgium, has notified Solvay SA that on November 15, SSOM crossed upwards the statutory declaration threshold of 3% of the existing voting rights emitted by Solvay SA, whereby the combined holding by Solvac and SSOM reached 33.71% of the existing voting rights.

SOLVAC SA is presumed to exercise de facto control over Solvay SA, and therefore SSOM, on the basis of Article 5, §3, 2nd paragraph of the Belgian companies code.

The declaration by SOLVAC SA is published in the Investor Relations Section of Solvay's website.

For the complete press release, please read the enclosed PDF.

       Follow us on twitter @SolvayGroup

Solvay is a multi-specialty chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability. Its lightweighting materials enhance cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 27,000 employees in 58 countries. Net sales were € 10.9 billion in 2016, with 90% from activities where Solvay ranks among the world's top 3 leaders. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.

Caroline Jacobs

Kimberly Stewart

Jodi Allen

Geoffroy Raskin

Bisser Alexandrov

Media Relations Investor Relations Investor Relations Investor Relations Investor Relations
+32 2 264 1530 +32 2 264 3694 +1 609 860 4608 +32 2 264 1540 +32 2 264 3687


To read the complete release in PDF

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Solvay S.A. via Globenewswire

Attachment: 826227.pdf
27 nov.: Euler Hermes : Projet d'offre publique d'achat simplifiée visant ..
27 nov.: GENFIT : Contribution significative à l'initiative européenne LIT..

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
Ingen indlæg

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine

Related stock quotes

Solvay 110,80 0,8% Cours en hausse

Buy and sell signals

  • Tendance
  • Moneymachine

Droit d'auteur Euroinvestor A/S 2018   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Morningstar.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
samedi 23 juin 2018 23:21:25
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180619.1 - EUROWEB5 - 2018-06-23 23:21:25 - 2018-06-23 23:21:25 - 4 - Website: OKAY